Background/Aims Direct‐acting antivirals (DAAs) have been approved for hepatitis C virus (HCV) treatment in patients with end-stage renal disease (ESRD) on hemodialysis. Nevertheless, the complicated comedications and their potential drug-drug interactions (DDIs) with DAAs might limit clinical practice in this special population.
Methods The number, class, and characteristics of comedications and their potential DDIs with five DAA regimens were analyzed among HCV-viremic patients from 23 hemodialysis centers in Taiwan.
Results Of 2,015 hemodialysis patients screened in 2019, 169 patients seropositive for HCV RNA were enrolled (mean age, 65.6 years; median duration of hemodialysis, 5.8 years). All patients received at least one comedication (median number, 6; mean class number, 3.4). The most common comedication classes were ESRD-associated medications (94.1%), cardiovascular drugs (69.8%) and antidiabetic drugs (43.2%). ESRD-associated medications were excluded from DDI analysis. Sofosbuvir/velpatasvir/voxilaprevir had the highest frequency of potential contraindicated DDIs (red, 5.6%), followed by glecaprevir/pibrentasvir (4.0%), sofosbuvir/ledipasvir (1.3%), sofosbuvir/velpatasvir (1.3%), and elbasvir/grazoprevir (0.3%). For potentially significant DDIs (orange, requiring close monitoring or dose adjustments), sofosbuvir/velpatasvir/voxilaprevir had the highest frequency (19.9%), followed by sofosbuvir/ledipasvir (18.2%), glecaprevir/pibrentasvir (12.6%), sofosbuvir/velpatasvir (12.6%), and elbasvir/grazoprevir (7.3%). Overall, lipid-lowering agents were the most common comedication class with red-category DDIs to all DAA regimens (n=62), followed by cardiovascular agents (n=15), and central nervous system agents (n=10).
Conclusions HCV-viremic patients on hemodialysis had a very high prevalence of comedications with a broad spectrum, which had varied DDIs with currently available DAA regimens. Elbasvir/grazoprevir had the fewest potential DDIs, and sofosbuvir/velpatasvir/voxilaprevir had the most potential DDIs.
Citations
Citations to this article as recorded by
Predictive value of osteoprotegerin and heart fatty acid binding protein as biomarkers for heart failure in chronic kidney disease patients on hemodialysis: A case-control study Saddam Jaber Khudiar, Rayah Sulaiman Baban, Arif Sami Malik Journal of Research in Pharmacy.2025; 29(2): 682. CrossRef
Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study Shou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Chao-Hung Hung, Chien-Hung Chen, Chi-Ming Tai, Pin-Nan Cheng, Hsing-Tao Kuo, Kuo-Chih Tseng, Lein-Ray Mo, Ching-Chu Lo, Yi-Hsiang Huang, Han-Chieh Lin, Pei-Lun Lee, Ming-Jong Bai Clinical and Molecular Hepatology.2025; 31(3): 899. CrossRef
Nationwide hepatitis C virus microelimination in uremic patients undergoing maintenance hemodialysis in Taiwan Chung-Feng Huang, Po-Cheng Liang, Yu-Ju Wei, Chao-Chun Wu, Shi-Lun Wei, Li-Ju Lin, Pei-Chun Hsieh, Tsui-Hsia Hsu, Maggie Shu-Mei Hsu, Ya-Xin Luo, Hsi-Chieh Chen, Tsu-Yun Ho, Shao-Hsuan Lin, Chia-Ling Liu, Kuo-Pen Cheng, John W. Ward, Ming-Lung Yu Journal of the Formosan Medical Association.2025; 124: S102. CrossRef
Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review Chen-Hua Liu, Yu-Ping Chang, Jia-Horng Kao Expert Opinion on Pharmacotherapy.2024; 25(12): 1691. CrossRef
Comorbidities and Contraindicated Medications in Patients with Chronic Hepatitis C Infection in Japan: a Real-World Database Study Takeya Tsutsumi, Hiroshi Yotsuyanagi Kanzo.2024; 65(8): 368. CrossRef
Enhancing hepatitis C management in ESRD: Evaluating efficacy and safety of alternative antiviral regimens Ume Aiman, Umer Bin Shahzad Therapeutic Apheresis and Dialysis.2024; 28(6): 967. CrossRef
TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes Ming-Lung Yu, Chih-Yuan Wang, Mei-Hsuan Lee, Horng-Yih Ou, Pin-Nan Cheng, Shih-Te Tu, Jee-Fu Huang, Jung-Fu Chen, Tsung-Hui Hu, Chih-Cheng Hsu, Jia-Horng Kao, Chien-Jen Chen, Han-Chieh Lin, Chien-Ning Huang Journal of the Formosan Medical Association.2023; 122(3): 202. CrossRef
Drug–Drug Interactions With Over-The-Counter Medicines: Mind the Unprescribed Oliver Scherf-Clavel Therapeutic Drug Monitoring.2022; 44(2): 253. CrossRef
Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5 Chen-Hua Liu, Jia-Horng Kao Hepatology International.2022; 16(5): 1001. CrossRef
Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report Mario Enrico Canonico, Giuseppe Damiano Sanna, Roberta Siciliano, Fernando Scudiero, Giovanni Esposito, Guido Parodi Frontiers in Pharmacology.2022;[Epub] CrossRef
Evaluation of US Food and Drug Administration Drug Label Recommendations for Coadministration of Antivirals and Acid‐Reducing Agents Tyler Shugg, Nicholas R. Powell, Patrick J. Marroum, Todd C. Skaar, Islam R. Younis Clinical Pharmacology & Therapeutics.2022; 112(5): 1088. CrossRef
Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study Vicki Wing-Ki Hui, Christopher Langjun Au, Amy Shuk Man Lam, Terry Cheuk-Fung Yip, Yee-Kit Tse, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Grace Lai-Hung Wong Hepatology International.2022; 16(6): 1318. CrossRef
Real-world experience of serial serum levels of GS-331007 in chronic hepatitis C hemodialysis patients during and after sofosbuvir/velpatasvir therapy Chung-Feng Huang, Yu-Ju Wei, Yu-Tse Wu, Yi-Wen Chiu, Ming-Lung Yu Journal of Hepatology.2021; 75(4): 1006. CrossRef
Background/Aims Obstacles exist in facilitating hepatitis C virus (HCV) care cascade. To increase timely and accurate diagnosis, disease awareness and accessibility, in-hospital HCV reflex testing followed by automatic appointments and a late call-back strategy (R.N.A. model) was applied. We aimed to compare the HCV treatment rate of patients treated with this strategy compared to those without.
Methods One hundred and twenty-five anti-HCV seropositive patients who adopted the R.N.A. model in 2020 and another 1,396 controls treated in 2019 were enrolled to compare the gaps in accurate HCV RNA diagnosis to final treatment allocation.
Results The HCV RNA testing rate was significantly higher in patients who received reflex testing than in those without reflex testing (100% vs. 84.8%, P<0.001). When patients were stratified according to the referring outpatient department, a significant improvement in the HCV RNA testing rate was particularly noted in patients from non-hepatology departments (100% vs. 23.3%, P<0.001). The treatment rate in HCV RNA seropositive patients was 83% (83/100) after the adoption of the R.N.A. model, among whom 96.1% and 73.9% of patients were from the hepatology and non-hepatology departments, respectively. Compared to subjects without R.N.A. model application, a significant improvement in the treatment rate was observed for patients from non-hepatology departments (73.9% vs. 27.8%, P=0.001). The application of the R.N.A. model significantly increased the in-hospital HCV treatment uptake from 6.4% to 73.9% for patients from non-hepatology departments (P<0.001).
Conclusions The care cascade increased the treatment uptake and set up a model for enhancing in-hospital HCV elimination.
Citations
Citations to this article as recorded by
Implementation of an alert system for the care cascade of Hepatitis C infection in patients undergoing elective surgery Jae Seung Lee, Ho Soo Chun, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Journal of Infection and Public Health.2026; 19(2): 103076. CrossRef
Challenges of an EMR‐Based Hospital Alert Program for Micro‐Elimination of Hepatitis C in Tertiary Referral Hospitals Hee Yeon Kim, Hae Lim Lee, Heechul Nam, Soon Kyu Lee, Ji won Han, Hyun Yang, Ahlim Lee, Pil Soo Sung, Seok‐Hwan Kim, Jihye Lim, Do Seon Song, Myeong Jun Song, Jeong Won Jang, U Im Chang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Seung Kew Yoon, Jung Hyun Journal of Viral Hepatitis.2026;[Epub] CrossRef
Hepatitis C virus‐free endoscope procedures project: An in‐hospital elimination approach Benjamin Lih‐Ren Hsieh, Yen‐Ting Kuo, Yu‐Ju Wei, Pei‐Chien Tsai, Ming‐Lun Yeh, Chung‐Feng Huang, Chia‐Yen Dai, Ming‐Yen Hsieh, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang The Kaohsiung Journal of Medical Sciences.2025;[Epub] CrossRef
Enhancing Hepatitis C Virus Testing, Linkage to Care, and Treatment Commencement in Hospitals: A Systematic Review and Meta-analysis Rebecca Mathews, Claudia Shen, Michael W Traeger, Helen M O’Brien, Christine Roder, Margaret E Hellard, Joseph S Doyle Open Forum Infectious Diseases.2025;[Epub] CrossRef
A Point‐of‐Care Model for Hepatitis C Elimination in Remote Islands of Taiwan Tzu‐Chun Lin, Pei‐Chien Tsai, Chung‐Feng Huang, Ming‐Lun Yeh, Yu‐Ju Wei, Ming‐Yen Hsieh, Ming‐Jong Bair, Chia‐Yen Dai, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang The Kaohsiung Journal of Medical Sciences.2025;[Epub] CrossRef
Differences among specialists in using the Electronic Medical Record alert system for HCV screening in outpatients at a large general hospital Cheng-Kuan Lin, Yu-Sen Peng, Chi-Yu Yang, Tyng-Yuan Jang, PLOS One.2025; 20(10): e0333940. CrossRef
‘One-stop-shop’ point-of-care hepatitis C RNA testing intervention in the prison – some issues Chia-Yen Dai, Batbold Batsaikhan, Chung-Feng Huang Journal of Hepatology.2024; 80(3): e106. CrossRef
Patient‐centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in Taiwan Chung‐Feng Huang, Tyng‐Yuan Jang, Shun‐Chieh Yu, Shin‐Chung Huang, Shao‐Lun Ho, Ming‐Lun Yeh, Chih‐Wen Wang, Po‐Cheng Liang, Yu‐Ju Wei, Po‐Yao Hsu, Ching‐I Huang, Ming‐Yen Hsieh, Yi‐Hung Lin, Sung‐Lin Yu, Pey‐Fang Wu, Yu‐Han Chen, Shin‐Chi Chien, Jee‐Fu H The Kaohsiung Journal of Medical Sciences.2024; 40(1): 86. CrossRef
Hepatitis C virus micro‐elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide Chi‐Ming Tai, Ming‐Lung Yu The Kaohsiung Journal of Medical Sciences.2024; 40(2): 112. CrossRef
Chronic viral hepatitis C micro‐elimination program using telemedicine in Guigang city Riying Lv, Yanmeng Lu, Wenyao Xiang, Menglan Meng, Shixiong Li Journal of Viral Hepatitis.2024; 31(4): 208. CrossRef
Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center Jae Seung Lee, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Journal of Gastroenterology and Hepatology.2024; 39(6): 1155. CrossRef
Improving the hepatitis C virus care cascade with the in‐hospital Reflex tEsting ALarm‐C (REAL‐C) model Jonggi Choi, Jina Park, Won‐Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Sujin Kwon, Sang‐Hyun Hwang Liver International.2024; 44(5): 1243. CrossRef
Recomendaciones para el diagnóstico integral de las hepatitis virales crónicas en una única extracción analítica Javier Crespo, Joaquín Cabezas, Antonio Aguilera, Marina Berenguer, María Buti, Xavier Forns, Federico García, Javier García-Samaniego, Manuel Hernández-Guerra, Francisco Jorquera, Jeffrey V. Lazarus, Sabela Lens, Elisa Martró, Juan Antonio Pineda, Martín Gastroenterología y Hepatología.2023; 46(2): 150. CrossRef
TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes Ming-Lung Yu, Chih-Yuan Wang, Mei-Hsuan Lee, Horng-Yih Ou, Pin-Nan Cheng, Shih-Te Tu, Jee-Fu Huang, Jung-Fu Chen, Tsung-Hui Hu, Chih-Cheng Hsu, Jia-Horng Kao, Chien-Jen Chen, Han-Chieh Lin, Chien-Ning Huang Journal of the Formosan Medical Association.2023; 122(3): 202. CrossRef
Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan – A multi-center collaborative care model Ching-Chu Lo, Wei-Yi Lei, Ying-Che Huang, Jow-Jyh Hwang, Chen-Yu Lo, Chien-hung Lin, Hsu-sheng Cheng, Yee-Tam Liao, Po-Cheng Liang, Meng-Jau Chiou, Ming-Jong Bair, Chia-Yen Dai, Ming-Lung Yu Journal of Microbiology, Immunology and Infection.2023; 56(4): 680. CrossRef
Response to antiviral therapy for chronic hepatitis C and risk of hepatocellular carcinoma occurrence in Japan: a systematic review and meta-analysis of observational studies Yoko Yamagiwa, Keitaro Tanaka, Keitaro Matsuo, Keiko Wada, Yingsong Lin, Yumi Sugawara, Tetsuya Mizoue, Norie Sawada, Hidemi Takimoto, Hidemi Ito, Tetsuhisa Kitamura, Ritsu Sakata, Takashi Kimura, Shiori Tanaka, Manami Inoue, Sarah Krull Abe, Shuhei Nomur Scientific Reports.2023;[Epub] CrossRef
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction Javier Crespo, Joaquín Cabezas, Antonio Aguilera, Marina Berenguer, María Buti, Xavier Forns, Federico García, Javier García-Samaniego, Manuel Hernández-Guerra, Francisco Jorquera, Jeffrey V. Lazarus, Sabela Lens, Elisa Martró, Juan Antonio Pineda, Martín Gastroenterología y Hepatología (English Edition).2023; 46(2): 150. CrossRef
A people-centered decentralized outreach model toward HCV micro-elimination in hyperendemic areas: COMPACT study in SARS Co–V2 pandemic Ching-I Huang, Po-Cheng Liang, Yu-Ju Wei, Pei-Chien Tsai, Po-Yao Hsu, Ming-Yen Hsieh, Ta-Wei Liu, Yi-Hung Lin, Meng-Hsuan Hsieh, Tyng-Yuan Jang, Chih-Wen Wang, Jeng-Fu Yang, Ming-Lun Yeh, Chung-Feng Huang, Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang, Ming Journal of Microbiology, Immunology and Infection.2023; 56(3): 586. CrossRef
Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith Clinical and Molecular Hepatology.2023; 29(2): 433. CrossRef
Reflex Hepatitis C Virus Viral Load Testing Following an Initial Positive Hepatitis C Virus Antibody Test: A Global Systematic Review and Meta-analysis Yusha Tao, Weiming Tang, Emmanuel Fajardo, Mengyuan Cheng, Shiyi He, Jennifer S Bissram, Lindsey Hiebert, John W Ward, Roger Chou, Francisco Rodríguez-Frías, Philippa Easterbrook, Joseph D Tucker Clinical Infectious Diseases.2023; 77(8): 1137. CrossRef
HCV Microelimination for High-risk Special Populations Chung-Feng Huang, Guan-Jhou Chen, Chien-Ching Hung, Ming-Lung Yu The Journal of Infectious Diseases.2023; 228(Supplement): S168. CrossRef
Policy and Strategy for Hepatitis C Virus Elimination at the National Level: Experience in Taiwan Rong-Nan Chien, Sheng-Nan Lu, Grace Hui-Min Wu, Wen-Wen Yang, Raoh-Fang Pwu, Chia-Ling Liu, Kuo-Pen Cheng, Shih-Chung Chen, Chien-Jen Chen The Journal of Infectious Diseases.2023; 228(Supplement): S180. CrossRef
Multi-disciplinary cooperation for the micro-elimination of hepatitis C in China: a hospital-based experience Lingling Zheng, Xiaoli Zhang, Yuxia Nian, Wenjuan Zhou, Dan Li, Yong Wu BMC Gastroenterology.2023;[Epub] CrossRef
Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation Andrea Marcellusi, Francesco Saverio Mennini, Murad Ruf, Claudio Galli, Alessio Aghemo, Maurizia R. Brunetto, Sergio Babudieri, Antonio Craxi, Massimo Andreoni, Loreta A. Kondili Liver International.2022; 42(1): 26. CrossRef
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison Chun-Ting Chen, Ming-Ying Lu, Meng-Hsuan Hsieh, Pei-Chien Tsai, Tsai-Yuan Hsieh, Ming-Lun Yeh, Ching-I Huang, Yi-Shan Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Ye World Journal of Gastroenterology.2022; 28(2): 263. CrossRef
Micro-Elimination of Hepatitis C among Patients with Kidney Disease by Using Electronic Reminder System—A Hospital-Based Experience Pei-Yuan Su, Wei-Wen Su, Yu-Chun Hsu, Shu-Yi Wang, Ping-Fang Chiu, Hsu-Heng Yen Journal of Clinical Medicine.2022; 11(2): 423. CrossRef
High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use: Some issues Chia-Yen Dai, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu Journal of Infection.2022; 85(4): e94. CrossRef
Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic Chi-Ming Tai, Chun-Kai Huang, Te-Chang Changchien, Po-Chun Lin, Deng-Wu Wang, Ting-Ting Chang, Hsue-Wei Chan, Tzu-Haw Chen, Cheng-Hao Tseng, Chih-Cheng Chen, Chia-Ta Tsai, Yu-Ting Sie, Yung-Chieh Yen, Ming-Lung Yu Viruses.2022; 14(8): 1637. CrossRef
The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment Jonggi Choi, Jina Park, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung Gut and Liver.2022; 16(6): 964. CrossRef
How to Optimize the Care Cascade of Hepatitis C Virus Infection Beom Kyung Kim Gut and Liver.2022; 16(6): 809. CrossRef
A People-Centered Decentralized Outreach Model Toward HCV Micro-Elimination in Hyperendemic Areas: COMPACT Study in SARS Co-V2 Pandemic Ching-i Huang, Po-Cheng Liang, Yu-Ju Wei, Pei-Chien Tsai, Po-Yao Hsu, Ming-Yen Hsieh, Ta-Wei Liu, Yi-Hung Lin, Meng-Hsuan Hsieh, Tyng-Yuan Jang, Chih-Wen Wang, Jeng-Fu Yang, Ming-Lun Yeh, Chung-Feng Huang, Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang, Ming SSRN Electronic Journal .2022;[Epub] CrossRef
Reflex Hepatitis C Virus Viral Load Reflex Testing Following an Initial Positive Hcv Antibody Test: A Global Systematic Review and Meta-Analysis Yusha Tao, Weiming Tang, Emmanuel Fajardo, Mengyuan Cheng, Shiyi He, Jennifer S. Bissram, Lindsey Hiebert, John W. Ward, Roger Chou, Francisco Rodríguez-Frias, Philippa Easterbrook, Joseph D. Tucker SSRN Electronic Journal .2022;[Epub] CrossRef
Elimination of hepatitis C: What would be the practical approach? Hyung Joon Yim Clinical and Molecular Hepatology.2021; 27(1): 97. CrossRef
Strategy for the Micro-Elimination of Hepatitis C among Patients with Diabetes Mellitus—A Hospital-Based Experience Pei-Yuan Su, Yang-Yuan Chen, Hsu-Heng Yen, Siou-Ping Huang, I-Ling Liu, Ya-Huei Zeng, Yu-Chun Hsu, Fu-Yuan Siao Journal of Clinical Medicine.2021; 10(11): 2509. CrossRef
Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study Hsu-Heng Yen, Pei-Yuan Su, I.-L.ing Liu, Ya-Huei Zeng, Siou-Ping Huang, Yu-Chun Hsu, Po-Ke Hsu, Yang-Yuan Chen BMC Gastroenterology.2021;[Epub] CrossRef
First
Prev
